3M in the news

Hastings, Minnesota, sued 3M over PFAS contamination in its drinking water due to emissions from 3M's manufacturing facility, seeking millions for treatment costs.

BlackRock reported beneficial ownership of 6.6% of 3M Company common stock, totaling 34,291,537 shares as of March 31, 2026.

3M's stock shows volatility due to dividend cuts and the Solventum spin-off, alongside ongoing legal challenges, yet displays adjusted earnings growth and a strong dividend yield.

The article questions if options traders have special knowledge about 3M stock, but access was interrupted due to a bot detection.

3M's stock is currently undervalued at $145.99, with a fair value estimate of $177.32, driven by operational efficiency gains, but risks include PFAS litigation.

3M's stock is volatile due to ongoing legal issues and a recent healthcare spin-off, but its core business is growing and its dividend is increasing.

3M returned $24 billion to shareholders, prompting an evaluation of its stock.

3M is undergoing a strategic transformation with a focus on data center technology and cost reduction, aiming for organic growth despite recent stock declines and market skepticism.

3M Company beat Q1 earnings expectations but saw its stock drop due to investor caution on the economic outlook, despite maintaining its full-year forecast.

3M's stock rose after beating profit estimates in Q1 2026 due to cost discipline, despite maintaining its full-year outlook and flagging higher oil costs.

3M, after spinning off its healthcare unit, is now a high-margin industrial powerhouse attracting defensive investors due to its essential products, predictable earnings, and strong shareholder returns.

3M exceeded Q1 2026 EPS estimates with strong margin recovery and surging orders, maintaining full-year guidance despite modest revenue growth.

3M's stock momentum is driven by industrial trends, restructuring, and broader US market indices affecting its diversified manufacturing business.

JPMorgan Chase & Co. cut 3M's price target to $178.00, while the company's Q1 earnings beat estimates and its stock saw varied analyst ratings and trading activity.

A recent analysis indicates 3M shares are potentially undervalued based on DCF, despite recent price weakness, while P/E ratios and differing narratives offer varied perspectives on its fair value.

3M Company's rating is upgraded to a Buy, citing a valuation pullback and emerging long-term catalysts despite mixed near-term fundamentals.

Wells Fargo & Company raised 3M's stock price target to $165.00, following 3M's Q1 earnings beat and reaffirmed FY2026 guidance.

3M reported first-quarter 2026 results, showing adjusted sales and earnings growth while reiterating its full-year guidance.

3M surpassed Q1 profit forecasts through cost controls, despite anticipating a $125 million annual cost increase from soaring oil prices.

RBC Capital lowered 3M's price target to $133 from $134 on PFAS liability concerns, despite a modest Q1 2026 operating beat and maintained dividends.